Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023)

Catheter Precision (VTAK) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $26.8 million as the latest value for Q4 2023.

Quarterly Long-Term Deferred Tax rose 207.88% to $26.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2023, up 207.88% year-over-year, with the annual reading at $26.8 million for FY2023, 207.88% up from the prior year.
Long-Term Deferred Tax for Q4 2023 was $26.8 million at Catheter Precision, up from $8.7 million in the prior quarter.
The five-year high for Long-Term Deferred Tax was $26.8 million in Q4 2023, with the low at $8.7 million in Q4 2022.